The 30-day period to initiate mandatory arbitration proceedings against apllicants of authorization to introduce generic medicines in the market is an expiration or final term.

A full summary of this case has been published on Kluwer IP Law


Leave a Reply

Your email address will not be published. Required fields are marked *